Custom Search

News

Thursday 23 June 2005

Eon Labs (ELAB) Receives Final Approval For Nitrofurantoin Monohydrate/Macrocrystals Capsules

By: Business Wire

Eon Labs (ELAB) Receives Final Approval For Bupropion HCl, ER 200mg Tablets And Will Begin Shipping Immediately.

Eon Labs, Inc. (Nasdaq: ELAB) announced today that it received final approval for Bupropion HCl, ER 200mg tablets, the generic equivalent of Wellbutrin SR(R)* 200mg tablets. The Company will begin shipping immediately. Eon Labs is a generic pharmaceutical company specializing in developing, licensing, manufacturing, selling and distributing a broad range of prescription pharmaceutical products.

Read Original Text

Use of this site is subject to the following terms of use